Deutsche Bank
NPCE icon

Deutsche Bank’s Neuropace NPCE Stock Holding History

Deutsche Bank’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.9M Buy
938,919
+6,829
+0.7% +$110K ﹤0.01% 939
2026
Q1 		$12.3M Buy
932,090
+2,568
+0.3% +$38.5K ﹤0.01% 992
2025
Q4 		$14.4M Buy
929,522
+756
+0.1% +$10.1K ﹤0.01% 977
2025
Q3 		$9.58M Hold
928,766
– – ﹤0.01% 1065
2025
Q2 		$10.3M Buy
928,766
+4,492
+0.5% +$56.2K ﹤0.01% 988
2025
Q1 		$11.4M Buy
924,274
+511,662
+124% +$6.4M ﹤0.01% 977
2024
Q4 		$4.62M Buy
412,612
+356
+0.1% +$3.1K ﹤0.01% 1369
2024
Q3 		$2.87M Sell
412,256
-241,429
-37% -$1.77M ﹤0.01% 1550
2024
Q2 		$4.94M Buy
+653,685
New +$6.6M ﹤0.01% 1254
2022
Q2 		– Sell
-3,857
Closed -$32K – 4261
2022
Q1 		$32K Sell
3,857
-460
-11% -$3.97K ﹤0.01% 3961
2021
Q4 		$44K Buy
4,317
+230
+6% +$2.99K ﹤0.01% 3991
2021
Q3 		$65K Sell
4,087
-46
-1% -$966 ﹤0.01% 4045
2021
Q2 		$98K Buy
+4,133
New +$95.9K ﹤0.01% 4154

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deutsche Bank's NPCE Position: Q2 2026 in Review

Deutsche Bank increased its Neuropace (NPCE) stake by 0.73% in Q2 2026, buying an estimated $110K and bringing the position to 938,919 shares worth $14.9M. The position accounts for ﹤0.01% of the portfolio, ranked #939.

Deutsche Bank first reported a position in NPCE in Q2 2021 and has held it in 13 quarters since. 113 funds tracked by Wall St. Rank hold NPCE as of Q2 2026.

  • Deutsche Bank held 938,919 shares of Neuropace worth $14.9M as of Q2 2026.
  • Deutsche Bank bought 6,829 Neuropace shares in Q2 2026, an estimated $110K.
  • Neuropace made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #939 holding.
  • Deutsche Bank first reported a position in Neuropace in Q2 2021 and has held it in 13 quarters since.
  • 113 funds tracked by Wall St. Rank held Neuropace as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.